Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05160532
PHASE2
Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
The purpose of this research is to learn more about treating Symptomatic Knee Osteoarthritis (OA) with an ultrasound-guided hypertonic dextrose injection. Researchers would like to determine best practice for injection frequency and effectiveness of the dextrose injection for symptomatic knee OA.
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2022-04-10
Completion Date
2025-05-31
Last Updated
2026-06-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
Placebo
5ml of normal saline (NS)
DRUG
Dextrose prolotherapy (DPT)
25% dextrose, mixing 2.5ml of sterile water and 2.5ml of 50% dextrose.
Locations (1)
Mayo Clinic in Arizona
Scottsdale, Arizona, United States